AllianceBernstein
QTTB icon

AllianceBernstein’s Q32 Bio QTTB Stock Holding History

AllianceBernstein’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,733
Closed -$150K – 3401
2022
Q1 		$150K Buy
2,733
+5
+0.2% +$311 ﹤0.01% 3053
2021
Q4 		$179K Hold
2,728
– – ﹤0.01% 3100
2021
Q3 		$386K Sell
2,728
-344
-11% -$43.8K ﹤0.01% 2862
2021
Q2 		$402K Buy
3,072
+644
+27% +$80.4K ﹤0.01% 2904
2021
Q1 		$411K Hold
2,428
– – ﹤0.01% 2757
2020
Q4 		$493K Buy
2,428
+511
+27% +$98.8K ﹤0.01% 2596
2020
Q3 		$369K Sell
1,917
-83
-4% -$18.6K ﹤0.01% 2698
2020
Q2 		$547K Buy
2,000
+194
+11% +$51.7K ﹤0.01% 2552
2020
Q1 		$505K Buy
1,806
+200
+12% +$61.3K ﹤0.01% 2350
2019
Q4 		$598K Buy
1,606
+117
+8% +$33.5K ﹤0.01% 2475
2019
Q3 		$485K Buy
1,489
+200
+16% +$68K ﹤0.01% 2561
2019
Q2 		$454K Buy
1,289
+233
+22% +$91.6K ﹤0.01% 2647
2019
Q1 		$527K Buy
1,056
+462
+78% +$207K ﹤0.01% 2501
2018
Q4 		$239K Buy
+594
New +$225K ﹤0.01% 2824

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein's QTTB Position: Q2 2022 in Review

AllianceBernstein sold out of Q32 Bio (QTTB) in Q2 2022, closing a stake of 2,733 shares — an estimated $150K sold.

AllianceBernstein first reported a position in QTTB in Q4 2018 and held it in 14 quarters. The position peaked at $598K in Q4 2019. 87 funds tracked by Wall St. Rank hold QTTB as of Q2 2022.

  • AllianceBernstein reported no remaining Q32 Bio position as of Q2 2022 after selling out during the quarter.
  • AllianceBernstein sold 2,733 Q32 Bio shares in Q2 2022, an estimated $150K.
  • AllianceBernstein first reported a position in Q32 Bio in Q4 2018 and held it in 14 quarters.
  • AllianceBernstein's Q32 Bio position peaked at $598K in Q4 2019.
  • 87 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.